Stay updated on Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Sign up to get notified when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.

Latest updates to the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page
- Check5 days agoChange DetectedAdded related topics: Schizophrenia and MedlinePlus Genetics. Updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check12 days agoChange DetectedRemoved the Schizophrenia topic and the MedlinePlus Genetics related topic from the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0, with no visible changes to the study details.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded related topics Schizophrenia and MedlinePlus Genetics, and updated the site revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check55 days agoChange DetectedDeleted the related topics 'Schizophrenia' and 'MedlinePlus Genetics' from the page.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded related topics 'Schizophrenia' and 'MedlinePlus Genetics', and updated the revision to v3.4.2. The prior government funding notice and the v3.4.1 reference were removed.SummaryDifference0.4%

Stay in the know with updates to Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.